Standout Papers
Citation Impact
Citing Papers
Cancer Biomarkers Defined by Autoantibody Signatures to Aberrant O-Glycopeptide Epitopes
2010
Membrane-tethered mucin-like polypeptides sterically inhibit binding and slow fusion kinetics of influenza A virus
2020 StandoutNobel
Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8
2004 StandoutScience
Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA
2004 StandoutScience
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway
2003 StandoutScience
Membrane curvature regulates the spatial distribution of bulky glycoproteins
2022 StandoutNobel
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
2017 StandoutNature
Prevention of cervical cancer through papillomavirus vaccination
2004
Innate immune sensing and its roots: the story of endotoxin
2003 StandoutNobel
Dendritic Cells: Translating Innate to Adaptive Immunity
2006 StandoutNobel
Interferons at age 50: past, current and future impact on biomedicine
2007
Physical Principles of Membrane Shape Regulation by the Glycocalyx
2019 StandoutNobel
Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release
2014
Epithelial Malignancies in Organ Transplant Patients: Clinical Presentation and New Methods of Treatment
2002
The cancer glycocalyx mechanically primes integrin-mediated growth and survival
2014 StandoutNatureNobel
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity
2007 StandoutNobel
Mucin-1 is expressed on dendritic cells, both in vitro and in vivo
2004
TRAM is specifically involved in the Toll-like receptor 4–mediated MyD88-independent signaling pathway
2003
Synthesis of tumor‐associated glycopeptide antigens for the development of tumor‐selective vaccines
2004
The Toll‐like receptor 7 (TLR7)‐specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily
2003
Flow cytometry-based assay to evaluate human serum MUC1-Tn antibodies
2010
DETECTION OF DISSEMINATED TUMOR CELLS IN PERIPHERAL BLOOD
2005
Effects of extracellular matrix viscoelasticity on cellular behaviour
2020 StandoutNature
Isolation of rare circulating tumour cells in cancer patients by microchip technology
2007 StandoutNature
Skin Cancers after Organ Transplantation
2003 Standout
Intracellular Toll-like Receptors
2010 StandoutNobel
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Cancer vaccines: between the idea and the reality
2003
IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage
2013 StandoutNobel
The challenge of emerging and re-emerging infectious diseases
2004 StandoutNature
Tumour-educated macrophages promote tumour progression and metastasis
2004 Standout
Therapeutics targeting the innate immune system
2004
Airway Mucus Function and Dysfunction
2010 Standout
Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages
2007 StandoutNobel
Recognition of Hyaluronan Released in Sterile Injury Involves a Unique Receptor Complex Dependent on Toll-like Receptor 4, CD44, and MD-2
2007 StandoutNobel
The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells
2008 StandoutNobel
Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway
2002 Standout
MUC1 and the MUCs: A Family of Human Mucins with Impact in Cancer Biology
2004
Lectin Domains of Polypeptide GalNAc Transferases Exhibit Glycopeptide Binding Specificity
2011 StandoutNobel
Recent advances in the discovery and delivery of vaccine adjuvants
2003
External Genital Warts: Diagnosis, Treatment, and Prevention
2002
Inferences, questions and possibilities in Toll-like receptor signalling
2004 StandoutNatureNobel
Pathogen Recognition and Innate Immunity
2006 Standout
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
2006 Standout
DNA Vaccines: Recent Developments and Future Possibilities
2006
Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions
2007 Standout
Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant
2009 StandoutNobel
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
2006 StandoutScience
Toll-Like Receptor Ligands Modulate Dendritic Cells to Augment Cytomegalovirus- and HIV-1-Specific T Cell Responses
2003
Intensified and protective CD4+ T cell immunity in mice with anti–dendritic cell HIV gag fusion antibody vaccine
2006 StandoutNobel
Tumor-Associated Tn-MUC1 Glycoform Is Internalized through the Macrophage Galactose-Type C-Type Lectin and Delivered to the HLA Class I and II Compartments in Dendritic Cells
2007
Density Variant Glycan Microarray for Evaluating Cross-Linking of Mucin-like Glycoconjugates by Lectins
2012 StandoutNobel
Structure and Function of the Cell Surface (Tethered) Mucins
2007
Characterisation of tumour‐derived microvesicles in cancer patients' blood and correlation with clinical outcome
2017
Lysosomal cathepsin D mediates endogenous mucin glycodomain catabolism in mammals
2022 StandoutNobel
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Crystal structure of Toll-like receptor adaptor MAL/TIRAP reveals the molecular basis for signal transduction and disease protection
2011 StandoutNobel
Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves
2009 StandoutNobel
Microbial nucleic acids pay a Toll in kidney disease
2006
Nod2-Dependent Regulation of Innate and Adaptive Immunity in the Intestinal Tract
2005 StandoutScience
Immunization with HIV-1 Gag Protein Conjugated to a TLR7/8 Agonist Results in the Generation of HIV-1 Gag-Specific Th1 and CD8+ T Cell Responses
2005
Chemically tunable mucin chimeras assembled on living cells
2015 StandoutNobel
In Vivo Targeting of Antigens to Maturing Dendritic Cells via the DEC-205 Receptor Improves T Cell Vaccination
2004 StandoutNobel
Details of Toll-like receptor:adapter interaction revealed by germ-line mutagenesis
2006 StandoutNobel
Live-Cell Labeling of Specific Protein Glycoforms by Proximity-Enhanced Bioorthogonal Ligation
2015 StandoutNobel
Immunotherapy: Bewitched, Bothered, and Bewildered No More
2004 StandoutScienceNobel
Stiffness Sensing by Cells
2019
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
2005 Standout
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
Imiquimod: modes of action
2003
A High-Throughput O-Glycopeptide Discovery Platform for Seromic Profiling
2010
The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling
2007 StandoutNobel
Induction of Antitumor Immunity by Vaccination of Dendritic Cells Transfected with MUC1 RNA
2000
The microbial mimic poly IC induces durable and protective CD4+T cell immunity together with a dendritic cell targeted vaccine
2008 StandoutNobel
Works of Michael Smith being referenced
A Randomized, Controlled, Molecular Study of Condylomata Acuminata Clearance during Treatment with Imiquimod
1998
Adjuvant Activities of Immune Response Modifier R-848: Comparison with CpG ODN
2000
Enhancement of the innate and cellular immune response in patients with genital warts treated with topical imiquimod cream 5%
1999
MUC1 and the Immunobiology of Cancer
2002
Treatment of External Genital Warts in Men Using 5% Imiquimod Cream Applied Three Times a Week, Once Daily, Twice Daily, or Three Times a Day
2001
Immunity to murine breast cancer cells modified to express MUC-1, a human breast cancer antigen, in transgenic mice tolerant to human MUC-1.
2000
Correlation between Pretreatment Levels of Interferon Response Genes and Clinical Responses to an Immune Response Modifier (Imiquimod) in Genital Warts
2000
Randomized, Single-Blind, Placebo-Controlled Studyof Topical Application of the Immune Response ModulatorResiquimod in HealthyAdults
2003
Viscosity-Independent Velocity of Neutrophils Rolling on P-Selectin In Vitro or In Vivo
2002